ATXI Stock Price History and Quote Analysis: Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ATXI shares is 10, representing 8.36% of the company's common stock.

ICON WEALTH PARTNERS, LLC, in the last quarter, reduced its stake in ATXI by -100% restricting it's holding to 0 shares of worth nearly N/A. N/A also lessened N/A of the ATXI shares from its portfolio, reducing its holding to N/A shares of worth N/A. N/A also shunned ATXI shares holding by N/A last quarter which brought its holding to N/A shares worth N/A.

As per its latest 13F filing, SHIKIAR ASSET MANAGEMENT INC increased its stake in ATXI by 100% in the last quarter. The institutional holder raised its holding to 25 thousand shares having worth more than $29.00K. N/A also added N/A more shares of ATXI to its portfolio, raising its holding to N/A shares of worth N/A. N/A also increased its ATXI shares holding by N/A which brought its holding to N/A shares worth N/A.

The insider with the most stakes in ATXI is Fortress Biotech, Inc. , 10 percent owner at the company. Additionally, ATXI stock is highly held by director ROSENWALD LINDSAY A MD and director Herskowitz Neil among others.

Company executives, directors, and other insiders own 1.25% percent of Avenue Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ATXI insiders have sold stock, totaling 0 shares. Insiders that have sold shares include DAVIDOW ROBERT L, INVAGEN PHARMACEUTICALS, INC., and VAZZANO JOSEPH WALTER.

There have been 0 transaction(s) during the past 6-months in which Avenue Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 0 Avenue Therapeutics, Inc. shares are held by insiders, which represents about 1.25% of ATXI stock.

ATXI 10 percent owner, Fortress Biotech, Inc. holds the largest portfolio of the company's shares. ATXI shares owned by Fortress total nearly 1.03 million.

SHIKIAR ASSET MANAGEMENT INC is the largest institutional owner in ATXI which holds 25 thousand shares worth $29.00K or 1.12% of the total ATXI shares outstanding followed by ICON WEALTH PARTNERS, LLC with ownership of 0 shares representing 0% of the ATXI ownership. N/A is the third largest stakeholder with N/A shares or N/A of the ownership worth more than N/A.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ATXI is concerned, it is a stock which is not optionable.

Number of ATXI shares short is 47.15K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 1.43M shares of ATXI are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ATXI has 1.29M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ATXI is 0.59.